Schedule 13G ownership disclosure

Palvella Therapeutics Inc

Common stock, $0.001 par value per share · CUSIP: 697947109

Event date: 2025-09-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • SUVRETTA CAPITAL MANAGEMENT, LLC

    Shares: 822,400.00 · Class: 7.4%

  • AVERILL MASTER FUND, LTD.

    Shares: 714,463.00 · Class: 6.5%

  • AARON COWEN

    Shares: 822,400.00 · Class: 7.4%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000919574-25-006758
Form type
SCHEDULE 13G/A
Filer
PALVELLA THERAPEUTICS, INC.
CIK
CIK 1583648
Filed
Nov 13, 2025
Reporting period
Sep 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub